MIM
OPTN

MetLife Investment Management’s OptiNose OPTN Stock Holding History

MetLife Investment Management’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,610
Closed -$57.2K – 2911
2024
Q1 		$57.2K Buy
+2,610
New +$57.9K ﹤0.01% 2696
2020
Q3 		– Sell
-1,070
Closed -$119K – 2323
2020
Q2 		$119K Buy
+1,070
New +$76.2K ﹤0.01% 2174
2018
Q4 		– Sell
-542
Closed -$101K – 2586
2018
Q3 		$101K Buy
+542
New +$155K ﹤0.01% 2347

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MetLife Investment Management's OPTN Position: Q2 2024 in Review

MetLife Investment Management sold out of OptiNose (OPTN) in Q2 2024, closing a stake of 2,610 shares — an estimated $57.2K sold.

MetLife Investment Management first reported a position in OPTN in Q3 2018 and held it in 3 quarters. The position peaked at $119K in Q2 2020. 84 funds tracked by Wall St. Rank hold OPTN as of Q2 2024.

  • MetLife Investment Management reported no remaining OptiNose position as of Q2 2024 after selling out during the quarter.
  • MetLife Investment Management sold 2,610 OptiNose shares in Q2 2024, an estimated $57.2K.
  • MetLife Investment Management first reported a position in OptiNose in Q3 2018 and held it in 3 quarters.
  • MetLife Investment Management's OptiNose position peaked at $119K in Q2 2020.
  • 84 funds tracked by Wall St. Rank held OptiNose as of Q2 2024.

Based on MetLife Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.